When Chinese authorities accused GlaxoSmithKline last summer of being
the “godfather” at the centre of a network of corruption, big pharma
braced for a prolonged period of turmoil in one of the world’s
您已閱讀4%（199字），剩余96%（4842字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。